TrialPsychiatry research2017

Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.

Jeffrey R Vittengl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.